NXTM - Nxstage Medical, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.56B
Enterprise Value 31.51B
Trailing P/E N/A
Forward P/E 1195.75
PEG Ratio (5 yr expected) 117.24
Price/Sales (ttm)3.95
Price/Book (mrq)7.31
Enterprise Value/Revenue 33.83
Enterprise Value/EBITDA 6116.82

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin -3.55%
Operating Margin (ttm)-1.74%

Management Effectiveness

Return on Assets (ttm)-1.33%
Return on Equity (ttm)-7.39%

Income Statement

Revenue (ttm)393.94M
Revenue Per Share (ttm)5.98
Quarterly Revenue Growth (yoy)11.40%
Gross Profit (ttm)168.29M
Net Income Avi to Common (ttm)-14.47M
Diluted EPS (ttm)-0.22
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.93M
Total Cash Per Share (mrq)0.98
Total Debt (mrq)14.34M
Total Debt/Equity (mrq)6.73
Current Ratio (mrq)3.23
Book Value Per Share (mrq)3.21

Cash Flow Statement

Operating Cash Flow (ttm)4.8M
Levered Free Cash Flow (ttm)26.27M

Trading Information

Stock Price History

Beta 0.09
52-Week Change 3-18.18%
S&P500 52-Week Change 314.10%
52 Week High 330.80
52 Week Low 320.45
50-Day Moving Average 324.43
200-Day Moving Average 326.34

Share Statistics

Avg Vol (3 month) 3495.59k
Avg Vol (10 day) 3422.3k
Shares Outstanding 566.32M
Float 60.85M
% Held by Insiders 12.06%
% Held by Institutions 184.11%
Shares Short 31.59M
Short Ratio 32.71
Short % of Float 32.45%
Shares Short (prior month) 31.31M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A